[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

BR112024002231A2 - Composição farmacêutica - Google Patents

Composição farmacêutica

Info

Publication number
BR112024002231A2
BR112024002231A2 BR112024002231A BR112024002231A BR112024002231A2 BR 112024002231 A2 BR112024002231 A2 BR 112024002231A2 BR 112024002231 A BR112024002231 A BR 112024002231A BR 112024002231 A BR112024002231 A BR 112024002231A BR 112024002231 A2 BR112024002231 A2 BR 112024002231A2
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
polyether
copolymer
polyester
pka
Prior art date
Application number
BR112024002231A
Other languages
English (en)
Inventor
Adolfo López-Noriega
Juliette Serindoux
Original Assignee
Medincell S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medincell S A filed Critical Medincell S A
Publication of BR112024002231A2 publication Critical patent/BR112024002231A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/31—Somatostatins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

composição farmacêutica. a presente invenção fornece uma composição farmacêutica compreendendo ou consistindo em pelo menos um copolímero de poliéter-poliéster, em que o copolímero tem a fórmula: b(a)n em que b representa um poliéter e compreende polietilenoglicol (peg), cada a representa um braço de poliéster e n é um número inteiro a partir de 1 a 8; pelo menos um composto nucleofílico; pelo menos um solvente orgânico; e até 10% (p/p) de pelo menos um composto ácido com um pka(h2o) inferior a 3.
BR112024002231A 2021-08-05 2022-08-05 Composição farmacêutica BR112024002231A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB202111321 2021-08-05
PCT/EP2022/072148 WO2023012357A1 (en) 2021-08-05 2022-08-05 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
BR112024002231A2 true BR112024002231A2 (pt) 2024-04-30

Family

ID=78212382

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112024002231A BR112024002231A2 (pt) 2021-08-05 2022-08-05 Composição farmacêutica

Country Status (10)

Country Link
US (1) US20250009647A1 (pt)
EP (1) EP4380546A1 (pt)
JP (1) JP2024530015A (pt)
KR (1) KR20240042032A (pt)
CN (1) CN118159252A (pt)
AU (1) AU2022323754A1 (pt)
BR (1) BR112024002231A2 (pt)
CA (1) CA3226943A1 (pt)
MX (1) MX2024001681A (pt)
WO (1) WO2023012357A1 (pt)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9211268D0 (en) 1992-05-28 1992-07-15 Ici Plc Salts of basic peptides with carboxyterminated polyesters
FR2741628B1 (fr) 1995-11-29 1998-02-06 Centre Nat Rech Scient Nouveaux hydrogels a base de copolymeres trisequences et leur application notamment a la liberation progressive de principes actifs
KR100566911B1 (ko) 2001-06-25 2006-04-03 주식회사 삼양사 약물 전달체용 음이온기-함유 양친성 블록 공중합체 및 그의 양이온성 약물과의 복합체
EP2462923A3 (en) 2003-07-18 2012-08-29 Oakwood Laboratories L.L.C. Prevention of molecular weight reduction of the polymer, impurity formation and gelling in polymer compositions
PT1824460E (pt) 2004-11-10 2015-01-14 Tolmar Therapeutics Inc Um sistema de administração polimérico estabilizado
CN101400363B (zh) 2006-01-18 2012-08-29 昌达生物科技公司 具有增强的稳定性的药物组合物
PT2658525T (pt) 2010-12-29 2017-11-30 Medincell Composições biodegradáveis de entrega de fármaco
US20160106804A1 (en) 2014-10-15 2016-04-21 Yuhua Li Pharmaceutical composition with improved stability
WO2018169950A1 (en) * 2017-03-13 2018-09-20 The Johns Hopkins University Injectable multidrug delivery hydrogel and uses thereof
JP7210816B6 (ja) 2017-07-17 2023-02-03 メディンセル エスアー 医薬組成物
GB201900258D0 (en) 2019-01-08 2019-02-27 Medincell Pharmaceutical composition

Also Published As

Publication number Publication date
KR20240042032A (ko) 2024-04-01
JP2024530015A (ja) 2024-08-14
CN118159252A (zh) 2024-06-07
AU2022323754A1 (en) 2024-02-08
WO2023012357A1 (en) 2023-02-09
EP4380546A1 (en) 2024-06-12
US20250009647A1 (en) 2025-01-09
CA3226943A1 (en) 2023-02-09
MX2024001681A (es) 2024-03-04

Similar Documents

Publication Publication Date Title
BR112018011608A2 (pt) material de revestimento de base, produto de reação à base de poliéter, uso de um produto de reação, método para produção de um sistema de pintura de multirrevestimento, e, sistema de pintura de multirrevestimento
BRPI0721056B8 (pt) moléculas indicadoras resistentes a oxidação
BR112012018074A2 (pt) "sistema de solventes com baixo voc"
AR111152A1 (es) Material plástico depurador de oxígeno
AR063555A1 (es) Derivados de androstano, su uso en la fabricacion de medicamentos, composiciones farmaceuticas que los comprenden y procesos para prepararlos
ES2531009T3 (es) Análogos sustituidos de dicetopiperazina para su uso como agentes para la administración de fármacos
AR030707A1 (es) 9-ALFA-CLORO-6-ALFA-FLUOR-17-ALFA-HIDROXI-16-METIL-17-BETA-METOXICARBONIL-ANDROST-1,4-DIENOS, UN PROCESO PARA SU PREPARACIoN , COMPOSICION FARMACEUTICA, Y EL USO DEL MISMO PARA LA FABRICACION DE MEDICAMENTO
BRPI0404348A (pt) Sistema para processar paráfrases por meio de técnicas de tradução mecânica
BR112017017208A2 (pt) composto de vedação, método para revestir um substrato, aeronave, e, usos de um composto de vedação e de um método.
ECSP034913A (es) Composiciones farmacéuticas que comprenden fármacos de solubilidad baja y/o sensibles a ácidos, y polimeros ácidos neutralizados
BRPI0610699A2 (pt) dispositivo de injeção
BRPI0414581B8 (pt) composto, composição farmacêutica compreendendo o referido composto e uso do referido composto
MX2008009705A (es) Composiciones farmaceuticas que contienen docetaxel, un inhibidor de degradacion y un proceso para obtener el mismo.
BRPI0605831A (pt) composição de revestimento de polìmero de emulsão de baixo teor de voc
BR112019023445A2 (pt) Um sistema agrícola
BR0313060A (pt) Composições farmacêuticas aquosas de 2,6-diisopropilfenol
BR0304269A (pt) Modelo estático para localização global
BR112015018259A2 (pt) Redução de resposta pró-inflamatória
BR112017025741A2 (pt) composição plastificante e seu uso, composição de polímero
CL2019000631A1 (es) Módulo flotante para plataformas de paneles solares modulares.
BR112017002950A2 (pt) película de poliéster termo retrátil
BR112017015740B8 (pt) Composições de fragrâncias e dispositivos para cuidados do ar
BR112021018171A2 (pt) Composto para o sequestro de anticorpos indesejáveis em um paciente
CL2022000330A1 (es) Composición farmacéutica que contiene un agente antifúngico como ingrediente activo
BRPI0408234A (pt) fluido para freios, e, uso do mesmo